CagriSema

1 entry tagged CagriSema. All writing.

TECHNOLOGY · SEPTEMBER 22, 2026 CagriSema vs. Tirzepatide: What the New Diabetes Trial Actually Shows Novo Nordisk says its experimental drug CagriSema beat Eli Lilly's tirzepatide on weight loss in a head-to-head diabetes trial. It did — against a 5mg dose, not tirzepatide's strongest one. A second trial released the same day, against the 15mg dose, went the other way.